Latest News

BOYDSense raises €7m in a capital increase to further develop its non-invasive glucose monitoring device

French channel France 3 report about BOYDSense solutions

The French media “La Tribune” puts BOYDSense in the spotlight

The French TV France 5 presents BOYDSense device

Conclusion of the 2nd BOYDSense clinical study

The French radio France Inter dedicates a report to BOYDSense

BOYDSense (an Alpha MOS subsidiary), selected among the 12 most innovative French Medtech by the National Union of the Medical Technology Industry (SNITEM)

BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury

BOYDSense selected in the Top 3 Diabetes Devices of the DCB Innovation Challenge 2022

Ben Delhey appointed as CEO of BOYDSense, the MedTech subsidiary of Alpha MOS